Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 26:12:1456235.
doi: 10.3389/fpubh.2024.1456235. eCollection 2024.

Prevalence of pulmonary hypertension and its associated factors among chronic obstructive pulmonary diseases patients at public hospitals of Addis Ababa, Ethiopia, 2024: a facility-based cross-sectional study

Tsehaynew Kasse  1 , Amanuel Elias  1 , Arega Abebe Lonsako  1 , Yalemzer Agegnehu  1
Affiliations

Prevalence of pulmonary hypertension and its associated factors among chronic obstructive pulmonary diseases patients at public hospitals of Addis Ababa, Ethiopia, 2024: a facility-based cross-sectional study

Tsehaynew Kasse et al. Front Public Health. .

Retraction in

Abstract

Background: Pulmonary hypertension (PH) is a serious medical condition characterized by elevated pressure in the lung blood vessels, with chronic heart and lung diseases being the most common causes worldwide. However, there is a dearth of studies on the prevalence of pulmonary hypertension and its associated factors among chronic obstructive pulmonary disease (COPD) patients in Ethiopia and the study area.

Objective: This study aimed to assess the prevalence of pulmonary hypertension and its associated factors among patients with chronic obstructive pulmonary disease at public hospitals in Addis Ababa, Ethiopia, 2024.

Methods: A facility-based cross-sectional study involving 422 COPD patients charted in Addis Ababa town, Ethiopia from May - June 2024 was conducted. Respondents' records were chosen using simple random numbers. Structured, and pretested questionnaires, were used to collect data. The data were coded and entered into EpiData 3.1 before being exported to SPSS version 25 for analysis. Logistic regression was employed to identify factors influencing the prevalence of pulmonary hypertension. Statistical significance was set at p < 0.05 with a 95% confidence interval.

Results: The study found the prevalence of pulmonary hypertension was 52% (95% CI: 49, 54.4%). Aged above 55 years [Adjusted Odds Ratio (AOR): 2.45 (1.55-3.9), Being male (AOR): 2.5 (1.5-4.1)]. Furthermore, having a history of alcohol [(AOR): 5.5 (2.4-13)], a history of smoking [(AOR): 4.6 (2.7-7.8), and congestive heart failure (AOR): 2.65 (1.5-4.6)], all increase the likelihood of pulmonary hypertension.

Conclusion: The study revealed a higher prevalence of pulmonary hypertension among COPD patients. Significant associations were found with being male, belonging to an older age group, and having a history of alcohol use, smoking, and congestive heart disease. Implementing screening programs, smoking cessation programs, educational initiatives, and counseling patients on lifestyle modifications were recommended.

Keywords: Addis Ababa; Ethiopia; adults; chronic obstructive pulmonary disease; pulmonary hypertension.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Schematic representation of the sampling procedure of COPD patients visiting the selected public hospitals in Addis Ababa, Ethiopia, 2024.
Figure 2
Figure 2
Prevalence of pulmonary hypertension among COPD adult patients visiting public hospitals hospital in Addis Ababa, Ethiopia, 2024.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Mocumbi A, Humbert M, Saxena A, Jing ZC, Sliwa K, Thienemann F, et al. Pulmonary hypertension. Nat Rev Dis Prim. (2024) 10:1. doi: 10.1038/s41572-023-00486-7 - DOI - PubMed
    1. Task A, Members F, Humbert M, Germany MMH, Berger RMF, Denmark JC, et al. 2022 ESC / ERS guidelines for the diagnosis and treatment of pulmonary hypertension developed by the task force for the diagnosis and treatment of (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lu. Eur Socciety Cardiol. (2022) 43:3618–731. doi: 10.1093/eurheartj/ehad005 - DOI
    1. Corris PA, Seeger W. Call it by the correct name — pulmonary hypertension not pulmonary arterial hypertension: growing recognition of the global health impact for a well- recognized condition and the role of the pulmonary vascular research institute. Am Physiol Soc. (2024) 318:L992–4. doi: 10.1152/ajplung.00098.2020 - DOI - PubMed
    1. Frost A, Badesch D, Gibbs JSR, Gopalan D, Khanna D, Manes A, et al. Diagnosis of pulmonary hypertension. Eur Respir J. (2018) 53:1801904. doi: 10.1183/13993003.01904-2018, PMID: - DOI - PMC - PubMed
    1. Sahay S, Tsang Y, Flynn M, Agron P, Dufour R. Burden of pulmonary hypertension in patients with portal hypertension in the United States: a retrospective database study. SAGE J. (2020) 10, 1–9. doi: 10.1177/2045894020962917 - DOI - PMC - PubMed

Publication types

LinkOut - more resources